PDM-35

3,5-dimethyl-2-phenylmorpholine (PDM-35)
Legal status
Legal status	CA: Unscheduled; DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act; US: Analogue to a Schedule I/II drug;
Identifiers
	IUPAC name 3,5-dimethyl-2-phenylmorpholine;
CAS Number	1218345-44-8;
PubChem CID	43367115;
DrugBank	Provide Please Provide;
UNII	B5FRU2US8C;
CompTox Dashboard (EPA)	DTXSID801342603 ;
	Provide&page2=PDM-35 (verify)

2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.^[1]

References

↑ HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

[1] HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.

[1]

This page was redesigned at the edge.

A page that knows where it met you.

PDM-35

See also

References